- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Shenzhen University
Total 221883 results
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedNon-small Cell Lung Cancer MetastaticChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Pharyngeal CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Adult Soft Tissue SarcomaChina
-
Shenzhen Zhongke Jingcheng Medical Technology Co...Chinese University of Hong Kong; Shenzhen Institute of Advanced Technology,...Recruiting
-
Per Torp SangildShenzhen People's Hospital; Sixth Affiliated Hospital, Sun Yat-sen University; Maternal and Child Health Hospital of Foshan and other collaboratorsCompletedNecrotizing Enterocolitis | Enteral Feeding Intolerance | Late-Onset Neonatal SepsisChina
-
HighTide Biopharma Pty LtdShenzhen HighTide Biopharmaceutical Ltd.RecruitingT2DM (Type 2 Diabetes Mellitus)China
-
Guangdong Provincial People's HospitalShenzhen Chipscreen Biosciences Co.LtdRecruitingMinimal Residual Disease | AML, AdultChina
-
Deutsches Herzzentrum MuenchenLifetech Scientific (Shenzhen) Co., Ltd.RecruitingLeft Atrial Appendage OcclusionGermany
-
Tianjin First Central HospitalShenzhen Third People's HospitalNot yet recruiting
-
HighTide Biopharma Pty LtdShenzhen HighTide Biopharmaceutical Ltd.Completed
-
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.Beijing 302 HospitalUnknownAdvanced Liver CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMalignant Solid TumourChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMalignant Solid TumourChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Ovarian CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedPancreatic CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMetastatic Renal Cell CancerChina
-
MGH Institute of Health ProfessionsShenzhen People's HospitalCompleted
-
Ma ShuzhenNot yet recruiting
-
Ma ShuzhenNot yet recruiting
-
Shenzhen Geno-Immune Medical InstituteThe Seventh Affiliated Hospital of Sun Yat-sen University; Shenzhen Children... and other collaboratorsRecruiting
-
Shengzhen Sciprogen Bio-pharmaceutical Co. LtdUnknownPatient of Anemia in Chronic Renal Failure With HemodialysisChina
-
Sun Yat-sen UniversityShenzhen Yunding Information Technology Co., Ltd.Recruiting
-
Shenzhen BinDeBio Ltd.The First Affiliated Hospital of Zhengzhou UniversityRecruitingGlioma | Melanoma | Lymphoma | Myeloid Leukemia | Multiple Myeloma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Mesothelioma | B-cell Acute Lymphoblastic Leukemia | Hepatoma | Synovial Sarcoma | Esophagus Cancer | Renal CarcinomaChina
-
Shenzhen Center for Chronic Disease ControlSun Yat-sen UniversityCompletedGrowth Disorders | Nutritional and Metabolic Diseases | Nutrition, Healthy | Development, Child | Nutritional Deficiency | Development, Adolescent | Nutrition Disorder, Child | Nutritional Stunting | Growth; Stunting, Nutritional | Nutritional Imbalance | Nutrition Disorders in AdolescenceChina
-
Shenzhen Center for Chronic Disease ControlSun Yat-sen UniversityCompleted
-
Zhinan Yin, Ph.D.Shenzhen Third People's HospitalUnknownMulti-drug Resistant TuberculosisChina
-
Shengzhen Sciprogen Bio-pharmaceutical Co. LtdCompleted
-
Chinese University of Hong KongKowloon Hospital; The Affiliated Hospital of Guangzhou Medical University (Guangzhou... and other collaboratorsUnknownBipolar DisorderHong Kong
-
Shenzhen Institute of Advanced Biomedical Robot...Not yet recruitingPercutaneous Coronary Intervention | Pan-vascular Interventional Robotic SystemChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Tongue CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Breast CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedPancreatic CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Non-small Cell Lung CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Laryngeal CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMalignant Solid TumourChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedNon-small Cell Lung Cancer MetastaticChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Cervical CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedBreast Cancer RecurrentChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMetastatic Nasopharyngeal CancerChina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMetastatic Colorectal CancerChina
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingRefractory T-Cell Lymphoma | T Cell Lymphoma in RelapseChina
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Plasmacytoid; LymphomaChina
-
Shenzhen BinDeBio Ltd.The First Affiliated Hospital with Nanjing Medical UniversityRecruiting
-
Zhiqing, LiangShenzhen Huada Genomics Co., Ltd.UnknownFemale Pelvic Floor DysfunctionChina
-
The University of Hong KongThe University of Hong Kong-Shenzhen HospitalCompleted
-
The University of Hong KongThe University of Hong Kong-Shenzhen HospitalUnknown
-
Shenzhen Second People's HospitalDongguan People's Hospital; Zhongshan People's Hospital, Guangdong, China; The... and other collaboratorsRecruitingChronic Myeloid Leukemia, Chronic Phase | NilotinibChina
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingT-cell Acute Lymphoblastic Leukemia | T-cell Non-Hodgkin Lymphoma | T-cell Acute Lymphoblastic LymphomaChina